<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H9085E0AE70C642029999EAEAAEB78E4C" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 6417 IH: Protecting Cures Act of 2020</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2020-03-31</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 6417</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20200331">March 31, 2020</action-date><action-desc><sponsor name-id="S001145">Ms. Schakowsky</sponsor> (for herself, <cosponsor name-id="P000607">Mr. Pocan</cosponsor>, <cosponsor name-id="W000822">Mrs. Watson Coleman</cosponsor>, <cosponsor name-id="N000002">Mr. Nadler</cosponsor>, <cosponsor name-id="S001175">Ms. Speier</cosponsor>, <cosponsor name-id="D000197">Ms. DeGette</cosponsor>, <cosponsor name-id="F000462">Ms. Frankel</cosponsor>, <cosponsor name-id="D000617">Ms. DelBene</cosponsor>, and <cosponsor name-id="H001068">Mr. Huffman</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To prohibit the Secretary of Health and Human Services from withholding funds for certain research using human fetal tissue, and for other purposes.</official-title></form><legis-body id="HC0E2FA2DE9874457BA4927D4D333CB2C" style="OLC"><section id="H27DE2E4295CE4CA9A30EA036DBE296AD" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Protecting Cures Act of 2020</short-title></quote>. </text></section><section id="H397204D29C4749A18CF011F2B4424AB1"><enum>2.</enum><header>Prohibition against withholding funds in cases of technical and scientific merit</header><subsection id="H30636462F13E4543BF6C8F191111B4CE"><enum>(a)</enum><header>In general</header><text>In the case of any proposal for research using human fetal tissue, the Secretary of Health and Human Services may not withhold funds because of considerations under subsection (b)(1) of section 492A of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/289a-1">42 U.S.C. 289a–1</external-xref>) if—</text><paragraph id="HC49EA1C3B39C4AD59E2E0F37640B43F7"><enum>(1)</enum><text>the research has been recommended for approval in accordance with paragraphs (1) and (2) of subsection (a) of such section 492A;</text></paragraph><paragraph id="H258656DDB1F64F0981043E263E359E32"><enum>(2)</enum><text>the research will be carried out in accordance with section 498A of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/289g-1">42 U.S.C. 289g–1</external-xref>); and</text></paragraph><paragraph id="HB5F1D11DAFD04E8D8F78013DE8898111"><enum>(3)</enum><text>there are reasonable assurances that the research will not utilize any human fetal tissue that has been obtained in violation of section 498B(a) of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/289g-2">42 U.S.C. 289g–2</external-xref>).</text></paragraph></subsection><subsection id="H5E0F69981CEC47F9AB1639E3B2982AFF"><enum>(b)</enum><header>Standing approval regarding ethical status</header><text display-inline="yes-display-inline">In the case of any proposal for research using human fetal tissue, the issuance of the report of the Human Fetal Tissue Transplantation Research Panel in December 1988 shall be deemed to be a report—</text><paragraph id="HE4131F7B4E3243169B4FC153DC61DCBC"><enum>(1)</enum><text>issued by an ethics advisory board pursuant to section 492A(b)(5)(B)(ii) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/289a-1">42 U.S.C. 289a–1(b)(5)(B)(ii)</external-xref>); and</text></paragraph><paragraph id="H375C8823802C4BD2B22DA661174499FE"><enum>(2)</enum><text>finding, on a basis that is neither arbitrary nor capricious, that the nature of the research is such that it is not unethical to conduct or support the research.</text></paragraph></subsection><subsection id="H611A3CCF5B4F457ABCE9B5B0F59D1966"><enum>(c)</enum><header>Definition</header><text>For purposes of this section, the term <term>human fetal tissue</term> has the meaning given such term in section 498A of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/289g-1">42 U.S.C. 289g–1</external-xref>).</text></subsection></section></legis-body></bill> 

